Fig. 1: Tumour immune microenvironment alterations post transarterial chemoembolisation versus Y-90 radioembolisation.

TACE transarterial chemoembolisation, TARE transarterial radioembolisation, Y-90 yttrium-90, SIRT selective internal radiation therapy, PBMC peripheral blood mononuclear cells, HIF hypoxia-induced factors, Treg regulatory T cells, DCs dendritic cells, Tex exhausted T cells, NK cell natural killer cell, GZB granzyme B, APCs antigen-presenting cells, ROS reactive oxygen species.